34421582|t|Agmatine Alleviates Epileptic Seizures and Hippocampal Neuronal Damage by Inhibiting Gasdermin D-Mediated Pyroptosis.
34421582|a|Background: Epilepsy is a common neurological disease, and neuroinflammation is one of the main contributors to epileptogenesis. Pyroptosis is a type of pro-inflammatory cell death that is related to epilepsy. Agmatine, has anti-inflammatory properties and exerts neuroprotective effects against seizures. Our study investigated the effect of agmatine on the core pyroptosis protein GSDMD in the context of epilepsy. Methods: A chronic epilepsy model and BV2 microglial cellular inflammation model were established by pentylenetetrazole (PTZ)-induced kindling or lipopolysaccharide (LPS) stimulation. H&E and Nissl staining were used to evaluate hippocampal neuronal damage. The expression of pyroptosis and inflammasome factors was examined by western blotting, quantitative real-time PCR, immunofluorescence and enzyme-linked immunosorbent assay (ELISA). Results: Agmatine disrupted the kindling acquisition process, which decreased seizure scores and the incidence of full kindling and blocked hippocampal neuronal damage. In addition, agmatine increased BV2 microglial cell survival in vitro and alleviated seizures in vivo by suppressing the levels of PTZ-induced pyroptosis. Finally, the expression of TLR4, MYD88, phospho-IkappaBalpha, phospho-NF-kappaB and the NLRP3 inflammasome was significantly upregulated in LPS-induced BV2 microglial cells, while agmatine suppressed the expression of these proteins. Conclusions: Our results indicate that agmatine affects epileptogenesis and exerts neuroprotective effects by inhibiting neuroinflammation, GSDMD activation, and pyroptosis. The inhibitory effect of agmatine on pyroptosis was mediated by the suppression of the TLR4/MYD88/NF-kappaB/NLRP3 inflammasome pathway. Therefore, agmatine may be a potential treatment option for epilepsy.
34421582	0	8	Agmatine	Chemical	MESH:D000376
34421582	20	38	Epileptic Seizures	Disease	MESH:D004827
34421582	43	70	Hippocampal Neuronal Damage	Disease	MESH:D009410
34421582	85	96	Gasdermin D	Gene	69146
34421582	106	116	Pyroptosis	Disease	
34421582	130	138	Epilepsy	Disease	MESH:D004827
34421582	151	171	neurological disease	Disease	MESH:D020271
34421582	177	194	neuroinflammation	Disease	MESH:D000090862
34421582	247	257	Pyroptosis	Disease	
34421582	275	287	inflammatory	Disease	MESH:D007249
34421582	318	326	epilepsy	Disease	MESH:D004827
34421582	328	336	Agmatine	Chemical	MESH:D000376
34421582	347	359	inflammatory	Disease	MESH:D007249
34421582	414	422	seizures	Disease	MESH:D012640
34421582	461	469	agmatine	Chemical	MESH:D000376
34421582	482	492	pyroptosis	Disease	
34421582	501	506	GSDMD	Gene	69146
34421582	525	533	epilepsy	Disease	MESH:D004827
34421582	546	562	chronic epilepsy	Disease	MESH:D002908
34421582	573	576	BV2	CellLine	CVCL:0182
34421582	597	609	inflammation	Disease	MESH:D007249
34421582	636	654	pentylenetetrazole	Chemical	MESH:D010433
34421582	656	659	PTZ	Chemical	MESH:D010433
34421582	681	699	lipopolysaccharide	Chemical	MESH:D008070
34421582	701	704	LPS	Chemical	MESH:D008070
34421582	719	722	H&E	Chemical	MESH:D006371
34421582	727	732	Nissl	Chemical	-
34421582	764	791	hippocampal neuronal damage	Disease	MESH:D009410
34421582	811	821	pyroptosis	Disease	
34421582	984	992	Agmatine	Chemical	MESH:D000376
34421582	1053	1060	seizure	Disease	MESH:D012640
34421582	1115	1142	hippocampal neuronal damage	Disease	MESH:D009410
34421582	1157	1165	agmatine	Chemical	MESH:D000376
34421582	1176	1179	BV2	CellLine	CVCL:0182
34421582	1229	1237	seizures	Disease	MESH:D012640
34421582	1275	1278	PTZ	Chemical	MESH:D010433
34421582	1287	1297	pyroptosis	Disease	
34421582	1326	1330	TLR4	Gene	21898
34421582	1332	1337	MYD88	Gene	17874
34421582	1347	1359	IkappaBalpha	Gene	18035
34421582	1369	1378	NF-kappaB	Gene	18033
34421582	1387	1392	NLRP3	Gene	216799
34421582	1439	1442	LPS	Chemical	MESH:D008070
34421582	1451	1454	BV2	CellLine	CVCL:0182
34421582	1479	1487	agmatine	Chemical	MESH:D000376
34421582	1572	1580	agmatine	Chemical	MESH:D000376
34421582	1654	1671	neuroinflammation	Disease	MESH:D000090862
34421582	1673	1678	GSDMD	Gene	69146
34421582	1695	1705	pyroptosis	Disease	
34421582	1732	1740	agmatine	Chemical	MESH:D000376
34421582	1744	1754	pyroptosis	Disease	
34421582	1794	1798	TLR4	Gene	21898
34421582	1799	1804	MYD88	Gene	17874
34421582	1805	1814	NF-kappaB	Gene	18033
34421582	1815	1820	NLRP3	Gene	216799
34421582	1854	1862	agmatine	Chemical	MESH:D000376
34421582	1903	1911	epilepsy	Disease	MESH:D004827
34421582	Negative_Correlation	MESH:D000376	17874
34421582	Positive_Correlation	MESH:D008070	18033
34421582	Negative_Correlation	MESH:D000376	18033
34421582	Positive_Correlation	MESH:D008070	21898
34421582	Negative_Correlation	MESH:D000376	MESH:D000090862
34421582	Negative_Correlation	MESH:D000376	MESH:D004827
34421582	Negative_Correlation	MESH:D000376	MESH:D010433
34421582	Positive_Correlation	MESH:D008070	MESH:D007249
34421582	Negative_Correlation	MESH:D000376	MESH:D007249
34421582	Negative_Correlation	MESH:D000376	MESH:D009410
34421582	Negative_Correlation	MESH:D000376	21898
34421582	Positive_Correlation	MESH:D008070	216799
34421582	Negative_Correlation	MESH:D000376	18035
34421582	Negative_Correlation	MESH:D000376	69146
34421582	Negative_Correlation	MESH:D000376	216799
34421582	Positive_Correlation	MESH:D008070	MESH:D002908
34421582	Positive_Correlation	MESH:D008070	18035
34421582	Negative_Correlation	MESH:D000376	MESH:D012640
34421582	Positive_Correlation	MESH:D008070	17874

